CMS Will “Walk Through” Medicare Drug Plan Applications Dec. 13
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will highlight “critical elements” that prospective Part D drug plan applicants should consider during an “open door” forum teleconference. CMS also will review its draft guidelines for evaluating PDP formularies.